MONROE, N.C.--(BUSINESS WIRE)--Greiner Bio-One North America, Inc. has added a new and innovative product to the already robust portfolio for cell culture that is specifically used for mass cell culture. CELLdisc™ is a new multilayer device covering a range of cell culture surfaces from 1,000 cm2 up to 1 square meter. The innovative ergonomic design of CELLdisc™ provides a versatile system for the propagation of adherent mammalian cells from research scale to industrial batches.
In addition, a centrally located channel allows a uniform distribution of gas throughout the device. A support rim guarantees that the bottom layer of the CELLdisc™ does not touch the surface of the incubator. The compact and robust cylindrical device is ideally suited for automation and upscaling of mass cell culture.
CELLdisc™ has many features that make it an ideal product for cell growth including:
- 40% higher surface/volume ratio than conventional multilayer systems
- Surface treatment for optimal cell attachment
- Gas inlet and outlet equipped with filters
- Easy accessibility due to wide opening port
- Optimal ventilation through central gas support channels
For additional information or media inquiries regarding this new product, please contact marketing@us.gbo.com.
About Greiner Bio-One North America, Inc.
Greiner Bio-One North America, Inc. is a privately held plastic manufacturing company located in Monroe, NC whose three divisions manufacture a variety of products for the medical and research fields. The manufactured products include plasticware for the cultivation and analysis of cell and tissue cultures, microplates for high-throughput screening related to drug screening, products for blood and specimen collection, tests for the detection of bacteria and viruses, as well as, custom-made products. As an international manufacturer with global reach, Greiner Bio-One provides the manufacturing, distribution logistics, and product application support to the world’s largest hospitals, pharmaceutical and biotechnology corporations.
